chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The symptoms started March 1, 2023. That day, I took a rapid COVID-19 test. The result was negative. The next day, the symptoms were worse. I had a dry cough, stuffiness, and loss of energy. I also had a slight fever. On March 2, 2023, I took another rapid COVID-19 test. The result was positive. I called my doctor's office to see if the recommended treatment. First, the nurse said no due to my age, but I asked the nurse to ask the doctor specifically due to my diabetes and hypertension. The doctor said it was reasonable to prescribe PAXLOVID. I stated PAXLOVID the evening on March 2, 2023. Since then, every day has gotten a little better. I'm on day five now. I have two doses left. The PAXLOVID has given me diarrhea and a bitter taste in the back of my mouth.
Patient woke at 0400 (approximately 18 hours after receiving vaccination) with increased pain, redness, induration, and swelling at/near injection site. Measured area of induration is approximately 5cm in circumference, hot, and hard to touch. There is also remarkable increase in circumference of R upper arm when compared with (non-vaccinated) L upper arm. Patient denies any other symptoms (no fever, chills, body aches, malaise, headache, or fatigue). The patient is afebrile at time of exam and has remained afebrile since receiving 2nd vaccine dose.
On March 9th Patient Had an Heart Attack. She was treated at Hospital. She was Discharged on March 12th.  On March 18th patient has a stroke. They admitted her and she was Discharged on  April 7th. 2021
Fever 102.8 on 8/2/2023, fever 100.8 on 8/3/2023,  rash developed on 8/2/2023 to nose and face, and then down arms and chest, mother notes no seizure activity noted
Information has been received from a pharmacist concerning a pt who was vaccinated with hep b vaccine recombinant. Subsequently the pt experienced a positive hep core antigen titer. Additional info has been requested.
Child was given Varicella and MMRV (PROQUAD) instead of Varicella and MMR.
Unexplained rash. Very itchy. Rash occurred all over body. Rash appearance different on each body part. Rash dissappears & returns. Approx. 1 week later went to Drs. I was put on Prednisone for 10 days with little effect. After prednisone I have been taking Benadryl. This helps alleviate the itch but not the strange rash. It has been 6 weeks I still have symptoms with less severity. Since the vaccine. I had a physical/pap smear. A vaginal yeast infection was discovered. On 3/18/2010 a prescription for Diflucan was issued. I have had 2 pay out of pocket for 2 drs visits & 2 prescription as well as several OTC for Benadryl. I can not afford to go to a dermatologist to find another way to keep this reaction @ bay. The bizzare reaction I think really needs to be noted as a possible side effect or allergy to vaccine.
Severe migraine, nausea and vomiting. Rest and ibuprofen, rizatriptan and Tylenol helped subside for both days
30 minutes after injection of vaccine, I developed tightness in my throat (not severe). This persisted for approximately 1 hour. Later in the evening around 1830, I developed chills and body aches. When I woke up the next day, all symptoms were gone.
Arm was hurting more than usual after receiving vaccination.  Site of administration was lower than deltoid muscle.
patient had rash on upper torso of body (from chest to waist area) starting the day after receiving vaccine. rash does not itch per patient. noticed that rash started to get progressively worse and along arm and leg extremity. spoke with physician and stated he has not had any changes in his routine. no new meds, foods or change in laundry detergent
Information has been received from a Licensed Practical Nurse and a Registered Nurse referring to a patient of unknown age and gender. Concurrent conditions and medical history of the patient were not reported. On 02-NOV-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (lot # K023328, expiry date 23-JUN-2016) (route and dose unspecified). Other suspect and concomitant therapies were not reported. No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
This spontaneous report as received from an other unspecified reporter refers to a female patient of unknown age. The patient's concurrent conditions included gastrooesophageal reflux disease, gas and peripheral pulmonic stenosis (PPS) murmur. The patient had no known drug allergies (NKDA) Concomitant therapies included ZANTAC and INFANTS MYLICON DROPS. On an unknown date the patient was vaccinated with ROTATEQ (lot # R000331, expiry date: 28-FEB-2019) (dose and frequency were not reported) intramuscularly (thigh) (incorrect route of product administration) for prophylaxis. Other suspect therapies included PREVNAR 13 (lot # T94428), HEPATITIS B VIRUS VACCINE (UNSPECIFIED) at birth (lot # 2372K) and DIPHTHERIA TOXOID (+) PERTUSSIS ACELLULAR VACCINE (UNSPECIFIED) (+) TETANUS TOXOID (lot # CS389AA) (dose, frequency and expiry date were not reported) intramuscularly (thigh) for prophylaxis. It was reported that, while taking a nap, the patient became dystonic and had trouble catching breath and started foaming at the mouth. The patient's electroencephalogram (EEG) and fingerstick Blood Sugar (FSBS) showed normal, at the hospital. The events lasted approximately 30 seconds to 1 minute. The patient was alert after event, but sleepy. The outcome of events, dystonia, foaming at mouth and dyspnoea was reported as recovered, on an unknown date. The outcome of event, somnolence was unknown. The relationship between the events and suspect drugs was not provided. No digital data logger was involved.
pt recvd vax; indurated, red area the size of a fist; 1st site became red;
I have seasonal allergies so it is hard to say if what I felt came from the vaccine or just my routine seasonal allergies.  Approximately 45 minutes after my shot I did start to experience what I recognize as allergy asthma which I have routinely every spring and fall.  Allergies I have year round.  I seem to be allergic to everything but I have been dealing with this all my life (since 10 years old).  I was asked if I have asthma but I responded no, which I don't have asthma I have what I have been told allergy asthma.  Plus I really wanted to be vaccinated for obvious reasons.  Now I am worried if I should get the second shot.  I am hoping you can advise me.  Other than the allergy asthma I experienced a feeling of being ill with needing a lot of rest for that day of the shot and the following two.  But I heard that is good news.
Patient was admitted for generalized weakness, observed overnight. Cardiology saw the patient believe that patient's weakness could be attributed to borderline hypotension. They will arrange outpatient Holter monitoring. Per the EUA, hospitalizations are to be reported irrespective of attribution to vaccine.
Adverse reaction began at 3:30 AM on 5/12/2021 with shaking, chills, fever (100-101.8), headache, muscle aches, fatigue, nausea and vomiting. There was pain, redness, and swelling at the injection site. PCP office was notified, and I began to alternate between 200 mg of Advil and 325 mg of Tylenol to manage the symptoms. I continued to have a fever throughout 5/12/2021 and 5/13/2021, and I missed two (2) days of work.
Breakthrough case admission after 4 vaccines Moderna 2/11/2 Lot# 031L20A;  Moderna 3/1/21 Lot# 001B21A;  Moderna 10/22/21 Lot# 040D21A;  Pfizer 10/14/22 Lot# GH9703
he is not sleeping due to itching a lot; He is very nervous; rashes on his face neck, back of neck, front, rashes around ear, more rashes on his body.; bumps (hives) around his ear on the top and bottom; not sleeping due to itching a lot; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (bumps (hives) around his ear on the top and bottom), PRURITUS (not sleeping due to itching a lot), INSOMNIA (he is not sleeping due to itching a lot), NERVOUSNESS (He is very nervous) and RASH (rashes on his face neck, back of neck, front, rashes around ear, more rashes on his body.) in a 24-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Apr-2021, the patient experienced URTICARIA (bumps (hives) around his ear on the top and bottom), PRURITUS (not sleeping due to itching a lot) and RASH (rashes on his face neck, back of neck, front, rashes around ear, more rashes on his body.). On an unknown date, the patient experienced INSOMNIA (he is not sleeping due to itching a lot) and NERVOUSNESS (He is very nervous). At the time of the report, URTICARIA (bumps (hives) around his ear on the top and bottom), PRURITUS (not sleeping due to itching a lot), INSOMNIA (he is not sleeping due to itching a lot), NERVOUSNESS (He is very nervous) and RASH (rashes on his face neck, back of neck, front, rashes around ear, more rashes on his body.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. No treatment was reported.
Hives. Shortness of breath. Chest pain. Itching. Swelling. Sent to ER immediately.
Diluent for Pfizer vaccine was less than recommended amount of 1.8ml resulting in higher than authorized dose. Patient was notified & educated on possible side effects. Patient will return for second dose at appointed time.
A bit dizzy; This case was reported by a consumer via interactive digital media and described the occurrence of dizziness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   In July 2022, the patient received Shingles vaccine. In July 2022, less than a day after receiving Shingles vaccine, the patient experienced dizziness. On an unknown date, the outcome of the dizziness was unknown.   It was unknown if the reporter considered the dizziness to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 14-JUL-2022 Reporter's comments: This case was reported by a patient via interactive digital media. The patient recently had 2nd dose of Shingles vaccine few hours ago from reporting and felt a bit dizzy. The reporter had also asked if this could be a side effect. Additional supportive information: Follow-up would not possible as no contact details were available.
R arm - swelling on 7/24/09 - site of 2 immunizations and a bug bite, swelling increased became hard and hot to touch called PMD on 7/26. Went to ER -> immunization reaction or from bug bite? -> swelling increased - no pain, fever, IV antibiotics started - adm.  8/17/09 Hospital records received DOS 7/26/09 to 7/28/09. Assessment: Cellulitis of Arm. Patient reports postvaccination pain treated with Tylenol. Patient presents with swelling of right arm, erythema, warmth, induration, itchy but now w/o pain. Mosquito bite on affected arm.
Pt present S/P 7 day following flu vaccination to (L) deltoid with healing bruising slightly larger than 1/2 dollar coin. Denies pain.
Persistent vomiting and diarrhea lasting for 2 which resulted in hospitalization for 5 days. Symptoms subsided after 15 days of onset.
Metallic taste in the mouth; Tongue went numb; Sore arm; This spontaneous case was reported by a patient and describes the occurrence of DYSGEUSIA (Metallic taste in the mouth), HYPOAESTHESIA ORAL (Tongue went numb) and PAIN IN EXTREMITY (Sore arm) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040-21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced DYSGEUSIA (Metallic taste in the mouth), HYPOAESTHESIA ORAL (Tongue went numb) and PAIN IN EXTREMITY (Sore arm). At the time of the report, DYSGEUSIA (Metallic taste in the mouth) outcome was unknown and HYPOAESTHESIA ORAL (Tongue went numb) and PAIN IN EXTREMITY (Sore arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 21-May-2021: Patient provided email address and wanted to have details of her second shot when she received it, for documentation purposes. On 22-May-2021: The patient stated that she had not experienced nausea
Significant myalgia, hives treated with non-rx medications Reports dizziness, headache, lightheadedness Axillary swelling/tenderness ipsilateral to the side of injection Injection site pain The patient was monitored for 15 minutes. She went to the restroom and noticed an erythematous rash to her chin, neck, and chest. Denies any itching. States that the affected areas are burning. Denies any CP, SOB, or difficulty swallowing. Denies any other medications today. Denies any other unique exposures. Pt given Benadryl 50 mg IM. She tolerated it well. She is discharged home. She is instructed to go to ER if she develops any SOB or difficulty swallowing.
Patient had dizziness, headache, blurred vision and double vision after first COVID-19 vaccine. Symptoms lasted 2 days.
This case was reported by a consumer via call center representative and described the occurrence of burning sensation in a 68-year-old female patient who received SHINGRIX (batch number EK279, expiry date unknown). The patient's past medical history included shingles. Previously administered products included ZOSTAVAX (received in 2009). Concomitant products included Atorvastatin, Vitamin D3, CREON, calcium, FLORASTOR Probiotic, Flax Seed Oil and trazodone. On 21st February 2018, the patient received the 1st dose of SHINGRIX 1 ml. In February 2018, 5 days after receiving SHINGRIX, the patient experienced burning sensation, scalp pain, nerve pain, temporal headache and interchange of vaccine products. On an unknown date, the outcome of the burning sensation, scalp pain, nerve pain and temporal headache were recovered/resolved and the outcome of the interchange of vaccine products was unknown. It was unknown if the reporter considered the burning sensation, scalp pain, nerve pain and temporal headache to be related to SHINGRIX. Additional information was received as follows: The concomitant products included OTC Senior MTV. The reporter requested the SHINGRIX without a prescription to prevent shingles. On 22nd January 2018, the patient was diagnosed with shingles on the right side of her back at the T3 and T4 area. The patient's pharmacist told her she could have the SHINGRIX after her shingles symptoms resolved. The patient received SHINGRIX vaccine, (left deltoid), after receiving ZOSTAVAX, which led to interchange of vaccine products. At times there was slight, mild burning sensation at the left scalp near the temple area under her hair near the hairline. The patient suspected the left scalp and left temple pain was mild nerve pain. The scalp and temple tenderness was mild and described as getting better. The pharmacy might be contacted. The reporter didn't know the zip code or name of pharmacist.
July 4th, 2021 @1pm Mountain Time - First symptoms.  Lost muscle control on right side of the face. July  4th 2021 @ 9:30pm Mountain Time - Entered Emergency Room and ruled out a stroke. Was diagnosed.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47-year-old male patient received BNT162b2 (BNT162B2), on 11Oct2021 as dose number unknown, single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: COVID 19 Treatment; (01Oct2022) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Patient received Paxlovid as COVID 19 Treatment, started on 21Sep2022 and stopped on 25Sep2022. Patient tested positive for Covid and Covid Symptoms approximately 6 days after finishing Paxlovid.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Non Ischemic cardiac myopathy, new onset out of the blue post vaccine .  Mom is celiac and concern that perhaps autoimmune response or trigger from vaccine / exposure ?
Patient reports slight chest tightness, cold, clammy upper extremities, jitteriness and slight tightness to the neck. Patient reports that she is anemic and did not eat this morning. Vitals were taken on site by team BP: 127/80 P: 92 and SPO2 ? 100% RA.
I became symptomatic. My initial symptoms were sore throat, continuous cough, sinus congestion and all the typical. I also developed a low grade fever with a sore throat. I took Tylenol and discussed with my midwife how much I could take since I was pregnant. I qualified for Paxlovid, but I did not take it. I used Tylenol for 2 days and I had blood in my mucus when I coughed. I consulted with the midwives again and they thought that from the coughing I had irritated the lining of my throat. I tested on May 6 and was positive. I did not get a negative test until day 12. I completely recovered from my symptoms in about 3 weeks.
pt received Pfizer covid 19 vaccine with mom in the room. Less than 5 minutes later, step dad reported that patient passed out and hit his head on the side. Pt was bleeding from the left forehead. A technician called 911. I wiped blood from the injury and applied a gauze and instant ice pack. pt was breathing and fully responsive. pt denied any other pain or discomfort other than the injury on the forehead and injection site pain in the arm.
Patient was administered Moderna Third dose of 0.5ml. Monitored for 15 minutes. No adverse reactions. Patient sent home. Dose to be administered Moderna Booster 0.25 ml. Covid vaccine manager and pharmacist notified. Per CDC guidelines, if administered 0.5ml as booster do not repeat dose. No adverse reactions listed. Patient notified of error. All questions  answered. Pt had no further questions or concerns.
Information has been received from a registered nurse concerning a 12 month old female patient who was vaccinated on 28OCT2003 with a dose of varicella virus vaccine live. One day prior to chickenpox break through, on 17NOV2003 the patient developed a fever. The patient presented to the doctor office on 17NOV2003, with 5 to 6 "pox" over the torso, and some on arm and face. It was noted that the patient had no treatment. It was also noted that the patient's outcome was not recovered. The nurse also stated that the varicella virus vaccine live had a temperature exposure during a hurricane and this was the vaccine that had the break through. No product quality complaint was involved. It was noted that two male patients form the same source, had similar experiences. Additional information has been requested.
he had rashes and redness in the chest stomach.; he had rashes and redness in the chest stomach.; breaking out in a rash with hives; This is a spontaneous report from a Pfizer Sponsored Program  received by a contactable consumer reported for himself. A male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 25Mar2021 as single dose for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient is scheduled to get the second dose of the COVID 19 vaccine tomorrow 15Apr2021. Last week, he had rashes and redness in the chest stomach on Apr2021. He asks if he can get the second dose appointment tomorrow. The patient had 2 questions regarding the vaccine first would which be possible delayed side effect. So, he received first dose of Pfizer vaccine (Covid-19 Vaccine) on 25Mar2021 and this week probably two or three days ago he started breaking out in a rash with hives. He wanted to know there have been reports of that late of the reaction to the vaccine. The second that was how long, like can he delay getting his second dose of vaccine and how long can he delay for because he was worried about going get to the vaccine while he had this rash that may or may not be part of his reaction to vaccine. Outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
The day after the shot, fairly violent chills/flu like symptoms that faded within a day or two.  A week after the shot, I had spasms in my legs that woke me up.  Since then, I have had numbness, nerve sensitivity and motor issues on the right side of my body as well as tingling on the right side (teh side of hte injection) .We do not know if hte damage is permanent, but it is new, had never happened before and has been persistent in different forms for a year.
MEDICAL PROBLEMS; This spontaneous report received from a consumer via a company representative concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient never ever had any of those medical problems. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported, 1 total administered for prophylactic vaccination. The batch number was not reported. Per procedure, no follow up will be requested for this case. No concomitant medications were reported. On an unspecified date, three weeks after the vaccination, the patient experienced medical problems, and was hospitalized (date and duration unspecified). The reporter stated "My daughter ended up in the hospital after taking their shot. It was about 3 weeks afterward and so I am just not completely sure the shot was the cause of it but I do know that she never ever had any of those medical problems before she got the shot". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of medical problems was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0-20220244707-Covid-19-vaccine ad26.CoV-2.s-Medical problems. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.
Dose 1 / on October 27, 2020 / Patient is experiencing a shingles outbreak; This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a 58-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 27th October 2020, the patient received the 1st dose of Shingrix (intramuscular). On 26th January 2021, 91 days after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix and experiencing a shingles outbreak.  The patient had not yet received the second dose. The reporter did not consent to follow up.